Drug Shortage Report for LANTUS

Last updated on 2022-01-27 History
Report ID 152697
Drug Identification Number 02294338
Brand name LANTUS
Common or Proper name Lantus Solostar
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN GLARGINE
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5
ATC code A10AE
ATC description INSULINS AND ANALOGUES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-01-21
Actual start date 2022-01-17
Estimated end date 2022-02-07
Actual end date 2022-01-25
Shortage status Resolved
Updated date 2022-01-27
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-01-27 French Compare
v5 2022-01-27 English Compare
v4 2022-01-21 French Compare
v3 2022-01-21 English Compare
v2 2022-01-13 French Compare
v1 2022-01-13 English Compare

Showing 1 to 6 of 6